0001209191-17-035160.txt : 20170524
0001209191-17-035160.hdr.sgml : 20170524
20170524200331
ACCESSION NUMBER: 0001209191-17-035160
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170522
FILED AS OF DATE: 20170524
DATE AS OF CHANGE: 20170524
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pulse Biosciences, Inc.
CENTRAL INDEX KEY: 0001625101
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 465696597
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1217
BUSINESS ADDRESS:
STREET 1: 849 MITTEN ROAD
STREET 2: SUITE 104
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650-697-3939
MAIL ADDRESS:
STREET 1: 849 MITTEN ROAD
STREET 2: SUITE 104
CITY: BURLINGAME
STATE: CA
ZIP: 94010
FORMER COMPANY:
FORMER CONFORMED NAME: Electroblate, Inc.
DATE OF NAME CHANGE: 20141113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DUGGAN ROBERT W
CENTRAL INDEX KEY: 0001055919
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37744
FILM NUMBER: 17867968
MAIL ADDRESS:
STREET 1: 611 SOUTH FORT HARRISON AVE
STREET 2: SUITE 306
CITY: CLEARWATER
STATE: FL
ZIP: 33756
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-22
0
0001625101
Pulse Biosciences, Inc.
PLSE
0001055919
DUGGAN ROBERT W
611 S. FORT HARRISON AVE., SUITE 306
CLEARWATER
FL
33756
0
0
1
0
Common Stock
2017-05-22
4
P
0
27928
26.149
A
3054244
D
Common Stock
2017-05-22
4
P
0
6800
26.667
A
3061044
D
Common Stock
2017-05-23
4
P
0
18600
26.688
A
3079644
D
Common Stock
2017-05-23
4
P
0
28600
27.628
A
3108244
D
Common Stock
2017-05-23
4
P
0
2000
28.074
A
3110244
D
Common Stock
35000
I
See footnote
This is the weighted average purchase price of the shares, which ranged from $25.45 to $26.43 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $26.46 to $26.819 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $26.172 to $27.082 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $27.19 to $28.014 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $28.035 to $28.182 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
Shares are held by Genius Accelerated LLC, of which the Reporting Person is the sole member and beneficiary.
Brian Dow, as Attorney-in-Fact for Robert W. Duggan
2017-05-24